The financing terms (75% of Nasdaq Minimum Price, 3 warrants per share) are highly dilutive. Monitor the actual pricing and size of any placement after the Dec 2 meeting. The 33.95% holder HiTron's support is likely needed for the share increase proposal which requires a majority of outstanding shares.
XCUR drugs
XCUR drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $1.06entry
- T+1 · 4d ago +1.89%α +2.25% · $1.08
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Exicure is seeking shareholder approval for a dilutive financing of up to $10M, a new equity plan covering 981,899 shares (15% of outstanding), and a doubling of authorized shares to 400M. The company has a $7M market cap, a net loss of $9.7M in 2024, and has experienced complete management turnover. The activist stake by Exicure HiTron (33.95% owner) adds context but the proxy itself shows no contested items.
Key Facts
- Proposal 3 authorizes up to $10M in private placement with units of 1 share + 3 warrants, at the lesser of $1.30 or 75% of Nasdaq Minimum Price
- Proposal 4 creates a 2026 omnibus plan reserving 981,899 shares (15% of outstanding), with automatic annual increases
- Proposal 5 doubles authorized common shares from 200M to 400M
- 6,545,995 shares outstanding as of record date; $7M market cap
- 2024 net loss of $9.7M; no revenue disclosed
- Exicure HiTron owns 33.95% of shares; filed SC 13D/A in July 2026
- All named executive officers (CEO, CFO) resigned in early 2026; current CEO Jung Soo Kim appointed Feb 2026
- No Say-on-Pay vote or shareholder proposals on the ballot
Financial Impact
Up to $10M gross proceeds from financing; potential dilution of up to 4x units sold (share + 3 warrants); authorized share count doubling from 200M to 400M
Risk Factors
- Massive dilution from up to $10M financing with 3:1 warrant coverage
- Authorized share increase could enable further dilutive issuances without additional votes
- Company has no revenue and continues to burn cash with $9.7M net loss
- Complete management and board turnover suggests operational instability
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001193125-26-457986 |
| Document: 0001193125-26-457986-index-headers.html | 0001193125-26-457986 |
| Document: 0001193125-26-457986-index.html | 0001193125-26-457986 |
| Document: 0001193125-26-457986.txt | 0001193125-26-457986 |
Track record
9 reports on XCUR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Press Release Bearish 5/10 Entry $1.07 Now $1.07 −0.00% settles Nov 18
- Nov 12, 20264d ago DEF 14A Bearish 6/10 Viewing Entry $1.06 to $1.08 Now $1.07 −0.94% ▼ −1.89% −2.25% vs SPY
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $1.08 to $1.11 Now $1.07 −0.93% ▲ +2.78% +1.46% vs SPY
- Sep 16, 20268w ago 8-K Bearish 7/10 Entry $1.33 to $1.35 Now $1.07 +19.55% ▼ −1.50% −0.37% vs SPY
- Jun 30, 202619w ago 8-K Neutral 2/10 Entry $2.08 to $1.98 Now $1.07 −48.56% ▼ −4.81% −4.67% vs SPY
- Jun 1, 202624w ago Press Release Neutral 4/10 Entry $3.11 to $3.16 Now $1.07 −65.59% ▲ +1.61% +2.30% vs SPY
- Jun 1, 202624w ago 8-K Neutral 3/10 Entry $3.33 to $3.11 Now $1.07 −67.87% ▼ −6.61% −6.75% vs SPY
- Apr 10, 202631w ago 8-K Neutral 3/10 Entry $3.85 to $3.79 Now $1.07 −72.19% ▼ −1.56% −2.77% vs SPY
- Mar 25, 202633w ago Press Release Bearish 8/10 Entry $4.61 to $4.42 Now $1.07 +76.79% ▲ +4.23% +2.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers